HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intravenous tissue plasminogen activator in central retinal artery occlusion.

AuthorsKhalil Ghasemi Falavarjani, Mehdi Modarres
JournalAmerican journal of ophthalmology (Am J Ophthalmol) Vol. 147 Issue 6 Pg. 1105; author reply 1105-6 (Jun 2009) ISSN: 1879-1891 [Electronic] United States
PMID19463547 (Publication Type: Comment, Letter)
Chemical References
  • Fibrinolytic Agents
  • Recombinant Proteins
  • Tissue Plasminogen Activator
Topics
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Fibrinolytic Agents (administration & dosage, therapeutic use)
  • Humans
  • Injections, Intravenous
  • Recombinant Proteins (administration & dosage, therapeutic use)
  • Regional Blood Flow (drug effects)
  • Retinal Artery (physiopathology)
  • Retinal Artery Occlusion (drug therapy, physiopathology)
  • Thrombolytic Therapy
  • Time Factors
  • Tissue Plasminogen Activator (administration & dosage, therapeutic use)
  • Treatment Outcome
  • Visual Acuity (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: